188 results on '"Morrisroe, Kathleen"'
Search Results
2. Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension
3. Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity
4. Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review
5. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis
6. Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications
7. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
8. Gertrude Herzfeld: The woman who dared to be a surgeon
9. Health Care Utilization: What Is the Cost of Caring for Scleroderma?
10. Outcomes of patients with diffuse systemic sclerosis eligible for autologous stem cell transplantation managed with conventional therapy
11. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
12. Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension.
13. Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy.
14. Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease.
15. Damage Trajectories in Systemic Sclerosis Using Group‐Based Trajectory Modeling
16. Frequency and implications of malnutrition in systemic sclerosis
17. Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease
18. Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis‐AssociatedPulmonary Arterial Hypertension
19. The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study
20. Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease
21. Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis related interstitial lung disease
22. Cancer and scleroderma: recent insights
23. Health Care Utilization
24. Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
25. The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
26. Fitting in an Unfit Society With Autism Spectrum Disorder: Case Report
27. Additional file 1 of Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
28. Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis
29. To use or not to use buprenorphine for illegally manufactured fentanyl
30. EVOLVE: The Australian Rheumatology Association’s ‘top five’ list of investigations and interventions doctors and patients should question
31. Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
32. A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults
33. Evaluation of patient and physician assessments of gastrointestinal disease activity in systemic sclerosis.
34. Tu1125 DECODING GASTROINTESTINAL SYMPTOMS IN SYSTEMIC SCLEROSIS: A CLUSTER ANALYSIS OF A LARGE NATIONAL PROSPECTIVE SYSTEMIC SCLEROSIS COHORT
35. Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis
36. Damage Trajectories in Systemic Sclerosis Using Group‐BasedTrajectory Modeling
37. To use or not to use buprenorphine for illegally manufactured fentanyl.
38. Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes
39. Incidence, Risk Factors, and Outcomes of Cancer in Systemic Sclerosis
40. Controversies and advances in connective tissue disease‐related pulmonary arterial hypertension
41. The clinical and economic burden of systemic sclerosis related interstitial lung disease
42. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
43. Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension.
44. Small intestinal bacterial overgrowth in systemic sclerosis
45. Occupational silica exposure in an Australian systemic sclerosis cohort.
46. The Effect of Headgear on Visual and Sensory Performance Outcomes in Female Lacrosse Players
47. The clinical and economic burden of systemic sclerosis related interstitial lung disease.
48. Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life
49. Additional file 1: of Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
50. The Australian Scleroderma Interest Group and database: 10 years of screening to save lives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.